How to buy Syros Pharmaceuticals stock - 14 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Syros Pharmaceuticals stock

Own Syros Pharmaceuticals stock in just a few minutes.

Syros Pharmaceuticals, Inc is a biotechnology business based in the US. Syros Pharmaceuticals shares (SYRS) are listed on the NASDAQ and all prices are listed in US Dollars. Syros Pharmaceuticals employs 103 staff and has a trailing 12-month revenue of around USD$15.1 million.

How to buy shares in Syros Pharmaceuticals

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Syros Pharmaceuticals. Find the stock by name or ticker symbol: SYRS. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Syros Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Syros Pharmaceuticals, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Syros Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Syros Pharmaceuticals share price

Use our graph to track the performance of SYRS stocks over time.

Syros Pharmaceuticals shares at a glance

Information last updated 2021-04-09.
52-week rangeUSD$6.4 - USD$15.65
50-day moving average USD$8.6325
200-day moving average USD$9.6464
Wall St. target priceUSD$16.57
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.951

Buy Syros Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Syros Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Syros Pharmaceuticals financials

Revenue TTM USD$15.1 million
Gross profit TTM USD$15.1 million
Return on assets TTM -28.32%
Return on equity TTM -99.02%
Profit margin 0%
Book value $1.611
Market capitalisation USD$422.2 million

TTM: trailing 12 months

Shorting Syros Pharmaceuticals shares

There are currently 4.9 million Syros Pharmaceuticals shares held short by investors – that's known as Syros Pharmaceuticals's "short interest". This figure is 21.2% up from 4.0 million last month.

There are a few different ways that this level of interest in shorting Syros Pharmaceuticals shares can be evaluated.

Syros Pharmaceuticals's "short interest ratio" (SIR)

Syros Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Syros Pharmaceuticals shares currently shorted divided by the average quantity of Syros Pharmaceuticals shares traded daily (recently around 777846.57097289). Syros Pharmaceuticals's SIR currently stands at 6.27. In other words for every 100,000 Syros Pharmaceuticals shares traded daily on the market, roughly 6270 shares are currently held short.

However Syros Pharmaceuticals's short interest can also be evaluated against the total number of Syros Pharmaceuticals shares, or, against the total number of tradable Syros Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Syros Pharmaceuticals's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Syros Pharmaceuticals shares in existence, roughly 80 shares are currently held short) or 0.1201% of the tradable shares (for every 100,000 tradable Syros Pharmaceuticals shares, roughly 120 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Syros Pharmaceuticals.

Find out more about how you can short Syros Pharmaceuticals stock.

Syros Pharmaceuticals share dividends

We're not expecting Syros Pharmaceuticals to pay a dividend over the next 12 months.

Syros Pharmaceuticals share price volatility

Over the last 12 months, Syros Pharmaceuticals's shares have ranged in value from as little as $6.4 up to $15.65. A popular way to gauge a stock's volatility is its "beta".

SYRS.US volatility(beta: 1.9)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Syros Pharmaceuticals's is 1.9034. This would suggest that Syros Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Syros Pharmaceuticals overview

Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are SY-1425, a selective retinoic acid receptor alpha agonist, which is in Phase II clinical trial for genomically defined subset of patients with acute myeloid leukemia and phase III clinical trial for patents with myelodysplastic syndrome; SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors; and SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia. It has target discovery, research collaboration, and option agreement with Incyte Corporation to identify therapeutic targets with a focus on myeloproliferative neoplasms; and a license agreement with TMRC Co. Ltd. for the development and commercialization of tamibarotene. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was founded in 2011 and is headquartered in Cambridge, Massachusetts.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site